Integra LifeSciences Holdings Corporation Revenue 2008–2025
Integra LifeSciences Holdings Corporation reported $1.64B of revenue for fiscal 2025. That was 1.5% higher than fiscal 2024. Compared with fiscal 2020, the change was +19.2%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $1.64B | +1.5% |
| FY 2024 | $1.61B | +4.5% |
| FY 2023 | $1.54B | -1.0% |
| FY 2022 | $1.56B | +1.0% |
| FY 2021 | $1.54B | +12.4% |
| FY 2020 | $1.37B | -9.6% |
| FY 2019 | $1.52B | +3.1% |
| FY 2018 | $1.47B | +23.9% |
| FY 2017 | $1.19B | +19.8% |
| FY 2016 | $992.08M | — |
| FY 2015 | $0 | — |
| FY 2014 | $0 | — |
| FY 2013 | $0 | — |
| FY 2012 | $0 | — |
| FY 2011 | $0 | — |
| FY 2010 | $0 | — |
| FY 2009 | $0 | — |
| FY 2008 | $0 | — |
Source: Integra LifeSciences Holdings Corporation SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open IART 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Integra LifeSciences Holdings Corporation reported $1.64B of revenue for fiscal 2025. That was 1.5% higher than fiscal 2024. Compared with fiscal 2020, the change was +19.2%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Integra LifeSciences Holdings Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeIntegra LifeSciences Holdings Corporation — frequently asked questions
What is Integra LifeSciences Holdings Corporation's revenue?
Integra LifeSciences Holdings Corporation (IART) reported revenue of $1.64B for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Integra LifeSciences Holdings Corporation's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.